Evidence-Based Medicine Guidelines
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcium-channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud's_phenomenon_in_systemic_sclerosis.
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud's_phenomenon_in_systemic_sclerosis. Accessed October 13, 2024.
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud's_phenomenon_in_systemic_sclerosis
Calcium-channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud's_phenomenon_in_systemic_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
ID - 457163
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud's_phenomenon_in_systemic_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
